Demographic, Clinical, Investigational and Etiological Profile of Patients with Cerebral Venous Thrombosis and Analysis of short term outcome. by Balakrishnan, R
DEMOGRAPHIC, CLINICAL, INVESTIGATIONAL AND 
ETIOLOGICAL PROFILE OF PATIENTS WITH CEREBRAL 
VENOUS THROMBOSIS AND ANALYSIS OF 
SHORT TERM OUTCOME 
DISSERTATION SUBMITTED FOR
BRANCH – I . D.M. (NEUROLOGY)
AUGUST 2009
THETAMILNADUDR.M.G.R.MEDICALUNIVERSITY
CHENNAI, TAMILNADU
BONAFIDE CERTIFICATE
This  is  to  certify  that  the  dissertation  entitled  “DEMOGRAPHIC, 
CLINICAL,  INVESTIGATIONAL  AND  ETIOLOGICAL  PROFILE  OF  PATIENTS  WITH 
CEREBRAL VENOUS THROMBOSIS AND ANALYSIS OF SHORT TERM OUTCOME” is a 
bonafide record work done by Dr. R.BALAKRISHNAN under my direct supervision 
and guidance,  submitted to the Tamil  Nadu Dr.  M.G.R.  Medical  University  in 
partial fulfillment of University regulation for DM, Branch I –Neurology. 
         Dr.M.Chandrasekaran.M.D.D.M. (Neuro)
     Professor of Neurology, 
Head of the Department of       
                                                      Neurology and Neuro Surgery,
Madurai Medical College,  
Madurai
DECLARATION
I  Dr. R. BALAKRISHNAN solemnly declare that the dissertation titled 
“DEMOGRAPHIC,  CLINICAL,  INVESTIGATIONAL  AND  ETIOLOGICAL  PROFILE  OF 
PATIENTS WITH CEREBRAL VENOUS THROMBOSIS AND ANALYSIS OF SHORT TERM 
OUTCOME” has been prepared by me. I also declare that this bonafide work or a part of 
this work was not submitted by me or any other for any award, degree, diploma to any 
other University board either in India or abroad.
This is submitted to The Tamilnadu Dr. M. G. R. Medical University, Chennai in 
partial fulfillment of the rules and regulation for the award of D.M. degree Branch – I 
(Neurology) to be held in August 2009.
Place: Madurai      Dr. R. BALAKRISHNAN
Date :
ACKNOWLEDGEMENT
It gives me great pleasure to acknowledge all those who guided, encouraged and 
supported me in the successful completion of my dissertation.
     First and foremost, I express my gratitude to Dr.S.M. Sivakumar., M.S. Dean (In-
charge), Government Rajaji  Hospital,  Madurai  for  granting permission to utilize the 
hospital materials for conducting this study.
I  express my deep sense of  gratitude and sincere thanks to  our  respected and 
beloved  Professor Dr. M. Chandrasekaran, M.D., D.M., Head of the department of 
Neurology  &  Neurosurgery,  Madurai  Medical  College,  Madurai  for  his  teaching, 
constant motivation and guidance in the conduct of this study.
I express my sincere thanks and gratitude to our Assistant  Professors  Dr.T.R. 
Gnaneswaran,  M.D.,D.M.,  Dr.  R.  Manivannan,  M.D.,D.M.,      Dr.  R.  Kishore, 
M.D.,D.M.,  Dr. P.K. Murugan, M.D.,D.M., and   Dr.C. Justin. M.D.,D.M.,  Dr. 
Senthur Pandiyan, M.D., for their valuable suggestions and support.
I  owe  my  sincere  thanks  to  all  those  patients  and  the  technical  staffs  who 
participated in the study for it is their cooperation which made this study possible.
CONTENTS
S.NO. CONTENTS PAGE NO.
1. INTRODUCTION 1
2. REVIEW OF LITERATURE 4
3. AIMS AND OBJECTIVES 39
4. MATERIALS AND METHODS 40
5. RESULTS 41
6. DISCUSSION 50
7. SUMMARY AND CONCLUSION 62
8. ANNEXURE
        BIBLIOGRAPHY
        PROFORMA
        MASTER CHART
        KEY TO MASTER CHART
INTRODUCTION
Cerebral venous / sinus thrombosis has been recognized since the early 19th 
century,  but  still  remains  a  diagnostic  and therapeutic  challenge.  Patients  with 
cerebral venous thrombosis usually presents with headache, seizures, papilledema, 
altered  sensorium  and  focal  deficits  due  to  thrombosis  of  intracranial  veins  / 
sinuses resulting in hemorrhagic infarction and increased intracranial tension.  The 
above  features  are  present  in  various  combinations  ranging  from syndrome  of 
raised intracranial pressure   without localization to deep altered sensorium and 
dense hemiparesis. Cerebral venous   thrombosis forms a distinctive subgroup of 
cerebrovascular disease in India and is a leading cause of mortality in women of 
reproductive age group. In India, most of the cases are seen in postpartum period 
in  women,  while  alcoholism  is  a  significant  risk  factor  in  males.  The  high 
incidence  of  postpartum  cerebral  venous  thrombosis  is  due  to  lack  of  proper 
hygiene resulting in high incidence of puerperal sepsis, high prevalence of anemia, 
and  restriction  of  water  intake  during  labour  as  a  cultural  practice.  Other 
predisposing  and  causative  factors  for  cerebral  venous  thrombosis  are  oral 
contraceptive pills intake,  procoagulant states,  internal malignancies,  infections. 
Cross et4 al noted “usually recovery is rapid and complete if the patient survives 
the  acute  episode”.  ¾  cases  of  cerebral  venous  thrombosis  in  pregnancy  and 
puerperium reported by him survived with good recovery. However in pre imaging 
era, cerebral  venous thrombosis has been diagnosed exclusively at autopsy and 
therefore  thought  to  be  always  lethal.   After  the  introduction  of  heparin  in 
treatment of cerebral venous thrombosis, mortality has come down significantly 
and most of the recent studies reporting mortality of     < 20% compared to earlier 
studies  which  reported  mortality  between 30 -  50%.  However  the  outcome  of 
cerebral venous thrombosis is highly unpredictable and it  is not unusual to see 
dramatic recovery in deeply comatose patients and sudden worsening of conscious 
patient due to extension of thrombus. With the advent of CT and MRI / MRV the 
diagnosis of   cerebral  venous thrombosis has improved significantly.  CT scan 
commonly shows hemorrhagic infarction with or without “cord” / “empty delta 
sign”.  MRI  /  MRV  diagnose  &  confirm  the  diagnosis  of    cerebral  venous 
thrombosis even if the CT scan is normal and also diagnose the thrombosis of 
cortical veins and deep veins. After introduction of MRI many of the cases earlier 
diagnosed as idiopathic intracranial hypertension have been noted to have sinus 
thrombosis.   Involvement  of  superior  sagital  sinus  of  varying  extend  with  or 
without involvement of transverse sinus and sigmoid sinus   with thrombosis of 
cortical  veins  has  been  reported.  Involvement  of  deep  venous  system  is  less 
common  than  the  superficial  venous  system  but  by  means  not  rare.  Due  to 
multifactorial  causation  of  this  condition,  and  puerperal  cerebral  venous 
thrombosis is the major group among cerebral venous thrombosis seen in Indian 
series  it  is  worthwhile  to  study  the  demographic,  clinical,  investigational  and 
etiological profile of patients with cerebral venous thrombosis and worthwhile to 
compare demography, clinical, radiological features and  analysis of short term 
outcome  between puerperal, non puerperal female and male patients with cerebral 
venous thrombosis  
                            REVIEW OF LITERATURE
              Cerebral venous thrombosis or sinus venous thrombosis, as the name 
implies is a condition which involves cerebral venous sinuses and veins together 
or independent of each other with thrombotic event of varied temporal evolution. 
The clinical presentation is varied ranging from syndrome of raised ICT without 
localization to seizures, focal deficits & deep altered sensorium2,3. Some patients 
even present as behavioral disturbances as the predominant clinical manifestation, 
confusing the picture with postpartum psychosis. Strokes resulting from cerebral 
venous  thrombosis  usually  affect  young  persons  particularly  women  in 
reproductive age group & carry high mortality if not managed adequately. The 
term primary  or  idiopathic  CVT is  used when no specific  etiological  factor  is 
evident. Secondary sino venous thrombosis results from a variety of causes that 
include injury,  infection,  hematological  disturbances,  dehydration etc.  In  India, 
CVT in early puerperal period is very common i.e. 10 – 12 times higher than in the 
west12. 
Historical background:                                                
The  wide  spectrum  of  clinical  feature  in  CVT,  the  varied  &  changing 
etiological  factors & the apparent rarity  of  the condition had made advance in 
knowledge slow & uneven.                                         Periods of relative neglect 
had been interspersed with burst of enthusiastic discussion. The earliest reference 
to CVT was that of Ribes in 18231.  He described in detail  the clinical  & post 
partum  findings  of  45  year  old  man  who  had  thrombosis  of  superior 
sagital  and lateral  sinuses,  subdural  effusion   and metastatic carcinoma in the 
brain.  The  first  case  of  puerperal  venous  thrombosis  was  reported  by  John 
Abercromobie in 1828.  His patient, a 21 year old woman, developed headache, 
delirium and initially  right  sided then generalized seizures  at  the  beginning of 
second week after delivary. Autopsy showed ischemic and haemorrhagic infarcts 
with thrombosed and sclerosed cortical veins. Quinke and Nonne identified the 
clinical  syndrome  of  pseudo  tumor  cerebri  (a  term  coined  later)  as  a  clinical 
counter part to sinus thrombosis. In 1940, Martin and then Martin and Sheehan 
focusing  on  postpartum  sinovenous  thrombosis  evoked  a  number  explanation 
including air embolism, embolism by way of paraveretebral venous plexus and 
damage to venous walls, secondary to venous engorgement of pregnancy.  Kalbag 
and Woolf, Sir Charles Symonds and others gave a precise clinical description of 
CVT after 1940. After introduction of CT scan and later with the use of MRI with 
MRV, diagnosis of CVT has become simpler as these imaging modalities are quite 
sensitive in detecting CVT. Several large series with confirmation of diagnosis by 
angiograms,  surgical  exploration,  and  autopsy  and recently  with  CT and MRI 
studies have been reported from Indian subcontinent.
Epidemiology:
                    The true incidence of CVT is unknown. Ehlers and Courville14 found 
only 16 superior sagital sinus thrombosis in a series of 12,500 autopsies (0.12%). 
Towbin found CVT in 9 % of 182 consecutive autopsies. However, with the more 
recent reports of large clinical series, the true incidence of CVT is probably higher 
than that derived from autopsy figures.  Exact figures   however remain elusive. 
People of all age groups may be affected by CVT but there is preponderance in 
young  women  because  of  specific  causes  like  use  of  oral  contraceptives, 
pregnancy and puerperium.  Puerperal CVT has been reported to account for up to 
15 – 20 % of “young stroke”. It is the commonest cause of stroke in young women 
in India. 50% of strokes in Indian women are related to pregnancy and puerperium 
and 95.5% of these are due to CVT. In western countries, the incidence of CVT 
related to pregnancy and puerperium ranges from 1 in 1666 – 10,000 pregnancies. 
CVT  has  been  reported  to  occur  in  4.5/1000  obstetric  admissions  in  India. 
Relevant venous anatomy: 
                   The cerebral venous system comprises of cerebral veins that empty 
into  dural  sinuses  which  then  drain  the  blood into  two internal  Jugular  veins. 
Embryologically, the entire cephalic drainage may be subdivided into an outer and 
superficial segment, which drains the scalp, underlying muscle and tendons, an 
intermediate  segment  which  drains  the  skull,  diploe  and  dura  matter,  and  a 
cerebral segment, consisting of the veins that drain the brain. The cerebral segment 
may be further subdivided into a superficial cerebral group of veins and a deep 
cerebral group of veins. The superficial cerebral veins coalesce on the Pial surface 
draining out the blood from the outer 1 or 2 cm of cortex   and the underlying 
white matter. Venous blood in these vessels travels in a centrifugal direction and 
ultimately terminates in one of the dural sinuses. The deep cerebral veins serve to 
drain  blood in  a  centripetal  direction  away  from deep white  matter,  the  basal 
ganglia, and the diencephalons. Tributaries draining many of the deep structures of 
the  cerebrum join veins  in  the  lateral  angles  of  the  ventricles  and form a sub 
ependymal plexus. The veins of this plexus empty into the internal cerebral veins, 
which join the great cerebral vein of Galen. 
Superior sagital sinus (SSS)
                 SSS lies in the attached border of the falx cerebri and runs from the 
foramen caecum to the occipital protuberance, where it joins straight sinus, lateral 
sinus and torcular herophilli i.e confluence of sinuses. The anterior part is narrow 
or sometimes absent or replaced by two superior cerebral veins that join behind the 
coronal suture. Consequently anterior part of sinus is often poorly visualized on 
angiography and in MRV and its isolated lack of filling is not sufficient to indicate 
thrombosis. The SSS receives superficial cerebral veins and drains major part of 
cortex.  It  also  receives  diploic  veins,  themselves  connected  to  scalp  veins  by 
emissary veins, which explains the incidence of SSS thrombosis after cutaneous 
infections  and  contusions.  SSS  and  other  sinuses  play  a  major  role  in  CSF 
circulation because they contain most of the arachnid villi & granulations in which 
most of the CSF absorption takes place.  Thus there is a direct dependency of CSF 
pressure accounting for the frequency of raised intra cranial pressure in SSS (or) 
lateral sinus (LS) thrombosis.
Lateral Sinus (LS) 
              The lateral sinus starts from torcular herophilli to the jugular bulb and 
consist of transverse & sigmoid portions. They drain blood from cerebellum, brain 
stem & posterior portion of cerebral hemispheres. They also receive some veins 
from middle  ear,  another  possible  source  of  septic  thrombosis.  Numerous  LS 
anatomic variations may be misinterpreted in sinus occlusion on angiography. The 
right LS is more of the direct continuation of SSS & frequently larger than left LS 
which receives most of its blood from straight sinus. In Hackers study transverse 
portions were not visualized on ipsilateral carotid angiogram in 14% cases on left 
side and 33% on right side,  where as sigmoid portions, which may be directly 
injected via cerebral veins failed to fill in 4% of cases on left side and was always 
demonstrated on the right side. An isolated lack of filling of a left transverse sinus 
is more suggestive of hypoplasia than of thrombosis.
Cavernous sinus 
                     This sinus drains venous blood from the orbit through ophthalmic 
veins and from anterior part of the base of the brain via spheno palatine sinus and 
middle cerebral veins. They empty into both superior & inferior petrosal sinuses 
and ultimately into internal  jugular  veins.  Because  of their  situation cavernous 
sinuses  are  often  thrombosed  in  relation  to  infections  of  the  face  or  sphenoid 
sinusitis. In contrast to other sinuses, infection is the leading cause of cavernous 
sinus thrombosis.
Cerebral veins: 
They can be roughly divided into 3 groups.
             1. Superficial cerebral veins.
             2. Deep cerebral veins.
             3. Veins of posterior fossa.
Superficial cerebral veins  
Some  of  the  cortical  veins,  the  frontal  parietal,  occipital  and  superior 
cerebral veins drain the cortex ascending to SSS while others mainly the middle 
cerebral  veins drain into the  cavernous sinus.  Trolard’s  great  anastamotic  vein 
connects the SS to middle cerebral veins, which are then connected to LS by vein 
of Labbe´. The cortical veins present some peculiarities that are important to know 
to understand some of  the  clinical  features  of  CVT.  They have thin walls,  no 
muscle fibers and no valves. These features allow for dilatation and reversal of 
blood flow when the sinus into which they drain are occluded. They are linked by 
various  anastamosis,  allowing  development  of  collateral  circulation 
(angiographically visible as corkscrew vesselS). This probably explains the good 
prognosis of some of the venous thrombosis.
Deep cerebral veins
                 The internal cerebral  and basal veins joins to form great vein of Galen ,  
which   continues  as  straight  sinus  drain  blood from deep white  matter  of  the 
cerebral hemispheres and from basal ganglia . In contrast to superficial system the 
deep system anatomy is always visualized on angiography, so that thrombosis is 
easily recognized.
Veins of posterior fossa:   These are 3 groups.  
              1. Superior veins draining into Galenic system.
              2. Anterior veins draining into petrosal sinuses.
              3. Posterior veins draining into the torcular or neighboring         
                        SS and LS.
They are variable in course and angiographic diagnosis of their occlusion is 
extremely difficult.
Microscopic Anatomy of Cerebral Veins and Sinuses.
                  Capillaries open into cerebral venules which apart from their wider 
lumen are indistinguishable from them. These venules join the small medullary or 
cortical  veins.  These  vessels  reach  the  ventricular  or  cortical  surfaces,  either 
directly or indirectly, after fusion with neighboring veins forming larger vascular 
stems. The walls of cerebral veins consist of an endothelial lined tunica intima. 
Surrounding the endothelium is a thin adventitial layer. Veins do not have clearly 
defined muscular layer or valves. There is little to suggest that the veins receive 
vasomotor innervation. As these vessels approach their destination they become 
more  fibrous  and  resemble  closely  the  structure  of  dural  sinus.  The  strategic 
location  of  the  sinuses  within  the  major  folds  or  junctions  of  dura,  the  firm 
attachment of the dura to base, and the tough fibrous consistency maintains the 
patency of the sinuses all the time. The walls of dural venous sinuses consist of an 
inner  lining  of  endothelium  and  an  outer  layer  essentially  the  same  as  dura 
elsewhere.  The  outer  layer  consists  chiefly  of  fibroblasts  and  large  interlaced 
bundles of collagenous fibres. A few nerve fibres, presumably afferent have been 
reported to innervate along the  dural  venous sinuses.  The walls  of  the venous 
sinuses are not uniformly smooth and in certain locations like middle third of SSS 
area thrown into folds or membranous irregularities. According to one hypothesis, 
these folds may perform valve like action, while other authors suggested that they 
may be important in maintaining laminar flow.
Causes of CVT:
               Several medical, surgical and gynaeco - obstetric ailments as well as a 
number of regional causes like infective, trauma, tumors etc. have been implicated 
in the causation and predisposition to CVT. Table (1) lists the recognized causes 
or predisposing conditions.  
Table 1:  causes of cerebral venous thrombosis.
A. SEPTIC DURAL VENOUS THROMBOSIS.   
   Local:    Sepsis, trauma
                  Intra cranial infections, abscess, empyema and meningitis  
                  Otitis media, Sinusitis
                  Tonsilitis, Stomatitis.
 Systemic: Bacterial (Typhoid, TB, Septicemia, Endocarditis)
                  Viral (Measles virus, Hepatitis viruses, Herpes simplex        
                            Viruses, HIV, Cytomegalo viruses)
                  Parasitic (Malaria, trichinosis)
                  Fungal (Aspergillosis).
B. NONSEPTIC DURAL SINUS THROMBOSIS. 
                 Altered Hemodynamic states 
                         Dehydration
                         Fever 
                         Cardiac failure.
                 Hematological disorders
                        Polycythemia vera
                        Secondary polycythemia  
                        Disseminated intravascular coagulation
     Thrombotic thrombocytopenic purpura
                        Heparin-induced thrombocytopenia
                        Sickle cell anemia                          
                        Paroxysmal Nocturnal hemoglobinuria  
                        Thrombocytosis 
     Leukemia 
                        Severe anemia 
                       Anti Thrombin –III Deficiency 
                       Protein C & S deficiency
                       Factor V Leiden
                       Antiphospholipid antibody syndrome
                Hormonal dysfunction 
                       Oral contraceptive use
                       Pregnancy and puerperium 
                       Androgens
                Trauma 
                      Penetrating & nonpenetrating head injuries 
               Surgery 
                      Cardiac pacemakers 
                      Jugular Venous Catheters
              Metabolic disorders
                      Homocystinuria 
                     Osteopetrosis
                     Diabetes mellitus 
              Neoplasia 
                      Meningioma  
                      Metastasis 
             Inflammatory disorders
                      Behcet’s disease
                      Sarcoidosis 
                      SLE
                      Wegners Garnulomatosis
                      Polyarteritis nodosa
                      Inflammatory bowel disease 
                             Ulcerative colitis 
                             Crohn’s disease                             
             Vascular disoders 
                      Atrerio venous malformation
                      Arterial occlusions 
                      Sturge weber syndrome 
CLINICAL PROFILE:
CVT  may  occur  at  anytime  from  infancy  to  old  age.  The  spectrum  of 
symptoms and signs among patients with CVT is remarkably variable.  Patients 
present  with  varying  combinations  of  headache,  seizures,  aphasia,  behavioral 
abnormalities, altered sensorium and focal deficits.  The onset may be acute (<2 
days, 20-30%), sub acute (2 days to 30 days, 50-60%) and chronic (>30 days, 
10-20%).  The presentation is acute in obstetric and infectious CVT while a slowly 
progressive  disease  is  more  common  in  inflammatory  and  idiopathic  cases. 
Bilateral papilledema and symptoms of raised intracranial pressure occur in those 
with large  sinus  (SSS and LS)  thrombosis  blocking CSF absorption.   Cortical 
deficit  like agnosia,  apraxia,  cortical  blindness and aphasia do occur but better 
recognized in mild illness with good sensorium. Some patients may present with 
psychotic features before manifestations of increased ICT / or focal deficits sets in. 
Monoplegia (brachial / crural) or Hemi paresis with leg more affected than arm, 
intact  language despite  right  hemiparesis are all  common but  generally  regress 
without residual deficits. Cranial nerve palsies are reported in 12% of all cases of 
cerebral  venous thrombosis.  The cranial  nerves that  have been described to be 
involved are III, IV, V, VI, VII, VIII, IX, X and XI, and the involvement can be 
multiple  or  single.  In rare cases,  cranial  nerve palsies can be the only sign of 
cerebral  venous  thrombosis,  especially  when  there  is  the  involvement  of  the 
transverse/sigmoid  sinus  (VI,  VII  and  VIII  cranial  nerves).  Along  with  other 
neurological events,  involvement of cranial  nerves is known from the previous 
literature; VI nerve palsy in one patient with lateral sinus thrombosis, diplopia due 
to VI nerve palsy and signs of V nerve irritation with temporal and retro-orbital 
pain,  it  has  also  long  been  known  as  the  Gradenigo  syndrome,  suggesting 
involvement of the nerves at the petrous apex. The unilateral or bilateral VI cranial 
nerve involvement can also be due to the intracranial  hypertension itself.   The 
involvement of the III, IV, V and VI cranial nerves can be due to the thrombosis of 
the anterior cavernous sinus. An involvement of the IX, X and XI cranial nerves is 
possible when the location of the thrombosis is in the posterior cavernous sinus or 
the internal jugular vein, or the deep venous system or the cerebellar veins. 
                  Cerebellar infarcts with edema acting like space occupying lesion, 
requiring  surgical  decompression  are  rarely  encountered.  Neuropsychological 
deficits  such as impaired anterograde memory,  dementia,  akinetic  mutism,  and 
abnormal movements such as athetoid movements and dystonia, can in rare cases 
be symptoms of deep cerebral venous thrombosis.
              A generalized encephalopathic illness without localizing signs or 
recognizable  features  of  raised  intracranial  pressure  is  another  pattern  of 
presentation  .A depressed  level  of  consciousness  is  the  most  constant  finding, 
varying from drowsiness to deep coma.  
Subarachnoid hemorrhage has been described as the initial presentation of dural 
sinus thrombosis. The exact cause of subarachnoid hemorrhage associated with 
cerebral  venous thrombosis is unknown. Isolated psychiatric symptoms such as 
irritability, anxiety, depression, psychosis, delirium and amnesia are known to be 
the prevailing symptoms of cerebral venous thrombosis. They can be misleading 
in the postpartum period. 
               Reversible parkinsonism and MRI diffusion abnormalities have been 
described as a presenting symptom of cortical venous thrombosis. Finally, cerebral 
venous thrombosis can also be asymptomatic, particularly in the case of lateral 
sinus thrombosis, which can be observed on a routine CT.  
             The following table shows the clinical features of CVT in various Indian 
studies. 
                                              Table – 2
Clinical features of CVT in various Indian series
No. Clinical Features Bansal etal17 
1980 
N =138 (%)
Srinivasan12 
     1983 
    N =135(%)
Nagaraja3
N 405(%)
1. Fever 62 16 -
2. Head ache 48 24 70.8
3. Vomiting 36 24 38
4. Seizures
   GTCS
   Focal
29
17
50
22
39.7
30.1
5. Dysphasia 25 5 -
6. Diplopia 1 - -
7. Nuchal rigidity 3 10 13
8 Deep  leg  vein 
thrombosis
10 - -
9 Altered 
sensorium
41 43 58
10 Papilledema 35 16 18.5
11 Ocular palsy - 2 11
12 Motor deficit 69 49 66.4
In one study by Ameri et al in 1992 showed the most common presenting 
symptoms and signs were headache, papilledema, seizures and motor and sensory 
deficits. The following table shows the clinical features in Ameri series (1992).
                                            Table – 3
               Clinical features described by Ameri et al 1992 18
No. Feature      No    Percentage
1. Head ache 83 75%
2. Papilledema 54 49%
3. Motor / sensory deficit 38 34%
4 Seizures 41 37%
5 Drowsiness, mental changes 
contusion or coma
33 30%
6 Dysphasia 13 12%
7. Multiple cranial or palsies 13 12%
8. Cerebellar incoordination 3 3%
9. Nystagmus 2 2%
10 Hearing loss 2 2%
11. B/L or alternating cortical 
signs
3 3%
                   The setting of puerperal CVT is quiet characteristic. A young 
multiparus women presents with headache, focal or multifocal seizures, fluctuating 
neurological deficits and declining sensorium during be second or 3rd week after a 
full term normal delivery.  Seizures are usually seen in clusters or status but are 
not very difficult to control with usual anti convulsants.
Table – 4
Timing of onset of symptoms to post partum period                         to various 
series
Post Partum
day
Bansal et al17 
             1980 
N =138(%)
Nagpal 
1983 
N =34(%)
Srinivasan12 
1983 
N=135(%)
Nagaraja 3 
 1987 
N= 200(%)
0 – 7 days 52 65 Maximum in 
first 10 days
30
7 – 14 days 32 64.5 Mostly within 
2 weeks
40
14  days  –  3 
months
16 0 15 -
>  3 months 0 10 0 -
Following 
abortion 
- 3.0 - 34
The rest developed CVT during pregnancy following oral contraceptives. In 
children and elderly, CVT may present with lethargy and stupor with headache 
without any focal deficits.  Nagaraja et al grouped clinical features of CVT in four 
categories depending upon the topographical venous involvement.
1. Presentation with seizures, focal deficits and progressively deteriorating 
consciousness.  Thrombosis involves the dural sinuses as well as cortical 
veins producing cerebral infarction.  Seizures may be focal, multi focal or 
generalized.  Paralysis  may  be  unilateral  or  bilateral  and  is  usually 
maximal in lower limbs.  Later during the course patient may manifest 
signs of cortical or cerebral herniation leading to coma and death.
2. Presentation  with  symptoms  and  signs  of  raised  intra  cranial  tension 
namely headache, vomiting and papilledema.  If thrombosis continues to 
dural sinuses, the course is usually slow and prognosis is favorable.
3. Occasionally  thrombosis  predominantly  involves  cortical  veins  and 
patient may present with features of space occupying lesion.
4. Rarely,  thrombosis  predominantly  involves  the  deep  venous  system. 
Patient manifest symptoms of raised intracranial tension, focal deficits. 
Choreoathetosis, ocular signs and coma.  If runs a fulminant course.
Cavernous sinus thrombosis is usually due to spread of infection from face, 
para nasal sinus or intra cranial venous sinuses.  It has a distinctive clinical picture 
where patient presents with fever,  chills,  toxemia with proptosis,  chemosis and 
painful  ophthalmoplegia,  initially  unilateral  but  often  becoming  bilateral. 
Papilledema and retinal hemorrhage indicate retinal vein thrombosis.
              .    
                                        
INVESTIGATIONS:
Computed  tomography  scan  with  contrast  injection  is  the  first  Neuro 
imaging examination  to  be  carried  out  when  CVT is  suspected  as  it  is  easily 
available and has good   sensitivity and specificity.  Plain CT scan helps to rule out 
other pathologies such as tumors. CT scan is initially abnormal in 81- 89% of 
cases of CVT.  Normal scans are particularly common early in the course. Some 
studies show normal scans up to 25- 40%.  CT signs of sinus thrombosis may be 
focal  or  generalized  and  may  result  from  the  thrombosis  it  self  or  form  its 
sequelae.  They are seen before or after the infusion of contrast.  Signs may be 
direct (evidence of thrombosis) or indirect sequelae to thrombosis). On plain CT 
scan, the thrombosed SSS may appear as an unusually dense triangle which is 
sometimes referred as “dense triangle sign” (Filled triangle sign) may be seen 60% 
of patients. Straight sinus and vein of Galen may also appear hyperdense before 
contrast when they are thromosed.  The “cord sign” which is pathognomonic of 
cortical vein thrombosis, is a round hyper density seen in several sequential slices 
due to the presence of thrombosis in the lumen of the vein.  It is present in 2-25% 
of  patients.  Intra  parenchymal  linear  hyper  intensities  representing  thrombosed 
intra  cerebral  veins have the same significance.  Indirect  signs include areas of 
ischemia  may  be  imaged  as  mixed  density  lesion  representing  hemorrhagic 
infarction.  Hematoma may also be seen.  The location of the lesion correlates well 
with the site of occluded vein.   Non hemorrhagic venous infarcts are  seen as 
hypodense areas which are not corresponding to arterial territories. Evidence of 
increased intracranial pressure such as cerebral edema, compression of ventricles 
(slit like ventricles), compression of sub arachnoid space may be seen. 
    The best known and most specific sign seen after contrast is “empty delta 
sign”20,38. This sign consists of a central lucency within the SSS or straight sinus 
surrounded  by  a  margin  of  contrast  enhancement.  Enhancement  of  the  falx, 
tentorium can be reliably imaged on contrast CT scan.  Isolated gyral or linear 
enhancement is seen may be interpreted as SAH. 
                In one Indian study by Dr.Nagaraja et al in 1989 in a study of 69 patients 
showed normal CT in around 10 % of patients.
                                            Table - 5
     CT features of puerperal CVT   N = 68 Nagaraja et al 19892
Non contrast Seen N %
Cord sign 14 21.9
Diffuse / focal edema 16 25.0
Hemorrhagic lesion 26 40.9
         Unilateral 22
         Bilateral 4
Non Hemorrhagic lesion 33 51.6
        Unilateral 16
        Bilateral 17
Hematoma 2 3.1
Normal 7 10.9
Entered scan : N : 25
   General enhancement 15 60
   Empty triangle sign 8 32
   Tentorial enhancement 4 16
   Normal 1 4
MRI  has  become  the  imaging  modality  of  choice  for  the  diagnosis  of 
suspected  CVT.   It  is  more  sensitive  than  CT  to  parenchymal  abnormalities, 
petectial haemorrhage, thrombus formation and blood flow.  MRI is superior than 
CT  in  providing  definitive  evidence  for  CVT.   MRI  findings  depend  on  the 
sequence used and stage (age) of thrombosis.  In standard spin Echo T1 and T2 
weighted MRI the main direct sign of CVT is the lack of expected signal flow 
void.  Alteration in blood flow hemoglobin degradation products in thrombosed 
veins produce signal changes in T1W, & T2W images suggest CVT.  At very early 
acute  stage  (day  1-5)  there  is  absence  of  flow void  and  the  thrombus  appear 
isointense  on  T1  and  hypo  intense  on  T2W  images  due  to  the  presence  of 
oxyhemoglobin in the intact red blood cells.  This MRI pattern is rarely seen due 
to the usual delays in presentation and performing MRI examination.
At the sub acute stage (day 6-21),  the thrombosis becomes hyperintense, 
initially  on  T1WI (day  6-9)  then  on  T2 WI  (day  10-15)  due  to  conversion  of 
oxyhemoglobin  to  methemoglobin.   Absence  of  flow  void  persists.  Increased 
signal intensities on both T1WI and T2WI images is be most frequent MRI finding 
in  patients  with  CVT.  This  pattern  lasts  until  (21-35  days)  after  the  onset  of 
thrombosis.
At the chronic stage, (>21-35 days) the MRI pattern is more variable.  The 
thrombosed sinus can either remain totally or partially occluded or can recanalize. 
In  most  patients,  the  chronic  thrombus  appears  heterogenous  becoming 
progressively isointense on T1W images, and isointense to hyperintense on T2W 
images.  These findings can last for years and can be mistaken for recurrent CVT.
Gadolinium administration  can  increase  be  sensitivity  of  the  plain  MRI. 
MRI is also sensitive for identifying the changes in the mastoid air cells. Echo 
planar T2 weighted MRI / Diffusion weighted MRI  is also useful in diagnosis of 
CVT.
Magnetic  resonance  venography  has  become the  imaging  modality  most 
widely used to establish the diagnosis of CVT.  MRI can be performed with time 
of flight (TOF) or phase contrast techniques.
Most imaging protocols utilize TOF technique due to its short acquisition 
time.  Absence of  signal  within  a  sinus  and its  non opacification  suggest  intra 
luminal thrombosis. Occluding thrombosis often appear hyper intense. MRV has 
limitation  with  false  positive  /  false  negative  diagnosis.   Non  dominant 
(hypoplastic) transverse sinus can be seen in up to 30% normal individual when 
using TOF MRV leading to erroneous diagnosis of CVT.
Cerebral CT venography, recently dynamic spiral CT techniques have been 
utilized to study cerebral venous circulation.  Can be performed easily and rapidly 
in  acute  setting.   Filling  defects  with  in  the  affected  sinuses,  sinus  wall 
enhancement and abnormal venous collaterals are the usual finding.
Conventional four vessel angiogram allows visualization of be entire venous 
phase.  In recent years, its utility has declined because of its invasive nature and 
greater availability of MRI / MRV and CT / CTV techniques.
Transcranial  Doppler  techniques  may  have  a  role  in  diagnosing  CVT. 
Thrombosis  of  SSS  /  deep  basal  vein  of  Galen,  Labbé  or  Rosenthal  can  be 
associated with increased    velocities in deep venous system. TCD evaluation may 
be  useful  in  monitoring  changes  in  venous  flow  and  response  to  treatment. 
Available data suggest the value of TCD in CVT is limited.
TREATMENT 
               Available treatment data from controlled trials favor the use of 
anticoagulants  in  patients  with CVT because  it  may reduce the  risk  of  a  fatal 
outcome and severe disability and does not promote ICH. In one prospective study 
by  Einhäupl  et  al28  which  compared  dose  adjusted  intravenous  heparin  with 
placebo in 20 patients, 8 patients in the heparin group recovered completely and 
none died,  whereas only 1 patient  in  the placebo group recovered fully  and 3 
patients died. Three patients with previous ICH recovered completely and no new 
hemorrhages  occurred  in  the  heparin  group,  whereas  in  the  placebo  group  2 
patients with pretreatment ICH died and 2 new hemorrhages were observed.
                The only other randomized trial compared body weight-adjusted 
subcutaneous low molecular weight heparin (LMWH) with placebo in 60 patients 
with CVT. A poor outcome defined as death or Barthel index < 15 was observed 
after 3 weeks in 6 of the 30 patients treated with LMWH (20%) compared to 7 of 
the 29 controls (24%). After 12 weeks, 3 patients (10%) in the LMWH group and 
6 patients (21%) in the placebo group had a poor outcome, which corresponds to a 
non significant absolute risk reduction of 11% in favor of the active treatment. No 
new ICH or secondary worsening of the 15 patients with pretreatment hemorrhage 
was observed in the LMWH group. A Meta analysis of these two trials showed 
that  the  use  of  anticoagulation  led  to  an  absolute  risk  reduction  in  death  or 
dependency of 13% with a relative risk reduction of 54%. Although this difference 
is  not  statistically  significant,  both  trials  show  a  consistent  and  clinically 
meaningful  trend  in  favor  of  anticoagulants  and  demonstrate  the  safety  of 
anticoagulant  therapy. However,  it  is  unclear,  whether treatment  with full-dose 
intravenous heparin or subcutaneously applied LMWH is equally effective. 
              There is currently no evidence from randomized controlled trials about 
the efficacy and safety of either systemic or local thrombolytic therapy in patients 
with CVT. Thrombolytic therapy has the potential to provide faster restitution of 
venous outflow and positive effects of local thrombolytic treatment of CVT have 
increasingly been reported from uncontrolled series. Patients were either treated 
with  heparin  and  urokinase  or  heparin  and  recombinant  tissue  plasminogen 
activator  (rtPA)  which  may  carry  less  bleeding  complications  due  to  its  clot 
selectiveness and shorter half-life. Two uncontrolled studies which used rtPA in 
combination  with  dose-adjusted  intravenous  heparin  included  a  total  of  21 
patients.  Both  studies  showed  recanalization  was  rapidly  achieved  local 
thrombolysis  may  carry  a  higher  risk  of  bleeding  complications  compared  to 
anticoagulation  particularly  if  pretreatment  ICH  is  present.  Currently,  local 
thrombolysis  may  be  a  therapeutic  option  for  patients  at  high  risk  for  a  poor 
outcome despite heparin therapy. The International Study on Cerebral Vein and 
Dural  Sinus  Thrombosis  (ISCVT)  identified  comatose  patients  may  define  a 
subgroup  of  patients  with  CVT  who  are  at  high  risk  of  death  despite 
anticoagulation who may be benefited from thrombolysis. If patients deteriorate 
despite adequate anticoagulation and other causes of deterioration have been ruled 
out, thrombolysis may be a therapeutic option in selected cases, possibly in those 
without intracranial hemorrhage
Heparin Therapy
               Dose-adjusted  intravenous  heparin  treatment  should  be  started 
immediately  with  a  bolus  of  3,000–5,000  IU  after  the  diagnosis,  even  if  a 
hemorrhagic infarct is present. Continuous treatment using an intravenous infusion 
system is started with 1,000–1,200 IU per hour, followed by an increase of 100–
200 IU per hour every 6–8 h until aPTT is doubled. Alternatively, LMWH (e.g. 
nadroparin  in  a  dose  of  180  antifactor  Xa  U/kg/24  h  administered  by  two 
subcutaneous injections daily) can be given particularly in uncomplicated cases. 
Heparin therapy should be  continued until  remission of  the  acute  stage  of  the 
disease  (normalizing  level  of  consciousness  or  remission  of  mental  confusion, 
improvement of headache and focal neurological deficits).
Oral AC
                After the acute stage, therapy is switched over to oral anticoagulants. 
Dose should be adjusted to international normalized ratio (INR) value with a target 
INR of 2.0–3.0. Effective anticoagulation must be ensured during adjustment of 
oral anticoagulants (warfarin or acenocoumerol). If CVT occurs during pregnancy, 
oral anticoagulants should be avoided due to its possible teratogenic effect and 
ability to pass the placenta. Oral anticoagulants with a target INR of 2.0–3.0 may 
be given for 3 months if CVT was secondary to a transient (reversible) risk factor 
and for 6–12 months if it was idiopathic.
Treatment of Seizures
                 The prophylactic use of antiepileptic drug in all patients with CVT is 
controversial. Whereas some authors recommend prophylactic treatment because 
of the high incidence of seizures (and series of seizures or even status epilepticus) 
and their possible detrimental effects on the metabolic situation during the acute 
phase of  the disease,  others restrict  the use of  anticonvulsants  to patients  with 
seizures. Although data are insufficient to give recommendations, these findings 
suggest that prophylactic treatment with antiepileptic drug may be a therapeutic 
option for  those  patients,  whereas it  is  not  warranted when there  are  no focal 
neurological deficits and no focal parenchymal lesions on brain scan (e.g. patients 
with isolated intracranial  hypertension).   Prolonged treatment  with antiepileptic 
drug for 1 year may be reasonable for patients with early seizures and hemorrhagic 
lesions on admission brain scan,  whereas in patients without  these risk factors 
AED therapy may be tapered off gradually after the acute stage 
Treatment of Elevated ICP
                 Although brain swelling is observed in about 50% of all patients with 
CVT on CT, minor brain edema needs no other treatment than oral anticoagulants 
which improves the venous outflow sufficiently to reduce ICP in most patients.  In 
patients  with isolated intracranial  hypertension and threatened vision,  a lumbar 
puncture with sufficient CSF removal to obtain a normal closing pressure should 
be performed before starting oral anticoagulants    24 h after the puncture. There 
are  no  controlled  data  but  acetazolamide  may  be  considered  in  patients  with 
persistent  papilledema.  Antiedematous  treatment  is  necessary  in  only  20%  of 
patients and should be carried out according to general principles of therapy of 
raised ICP (head elevation at about 30º , hyperventilation with a target PaCO2 
pressure of 30–35mm Hg, intravenous application of osmotic diuretics). However, 
osmotic substances might be harmful in venous outflow obstruction since they are 
not as quickly eliminated from the intracerebral circulation as in other conditions. 
Steroids can not be generally recommended for treatment of elevated ICP since 
their efficacy is unproven and they may be harmful through their promotion of the 
thrombotic process. Treatment of Septic CVT
               Septic CVST almost always occurs in patients with bacterial cranial 
infections.  Treatment  includes  the  early  administration  of  systemic  antibiotics, 
surgical  removal  of  the  infectious  focus  and  the  use  of  oral  anticoagulants. 
Antibiotics  should  be  chosen  according  to  the  bacteria  found  after  surgical 
removal, in the CSF, blood samples or in smear examinations. Treatment should 
be started with antibiotics which are highly effective against bacteria commonly 
found in infections of the face, neck or ear. The effect of heparin in septic CVT 
has not been systematically investigated but most authors favor the use of heparin. 
Outcome
                Even though it was previously thought that CVT was often leading to 
death, it  was suggested already in 1953 that without additional morbid factors, 
many patients with intracranial venous thrombosis may be capable of recovery. 
There are several studies of long-term survival after CVT. However, only four of 
these  studies  contain  more  than  100  patients,  and  the  International  Study  on 
Cerebral Vein and Dural Sinus Thrombosis (ISCVT) is by far the largest study. 
The majority of deaths after CVT occur during the first days and months after 
onset of the disease. In the ISCVT, 4.3% were dead at discharge, 6.8% after 6 
months and 8.3% at last follow-up (which took place after a median of 16 months 
in that report).  Death after the acute phase may often be caused by underlying 
serious  disease,  e.g.  cancer.  Focal  deficits  and  cancer  in  the  acute  phase  are 
independent predictors of dependence or death at 3 years. However, even though 
most patients with CVT survive, no less than 3/4 of these survivors have been 
reported  to  have  some  residual  symptoms.  The  prognosis  after  CVT  during 
pregnancy and puerperium is probably better than after CVT from other causes. 
AIMS AND OBJECTIVES
1.  To study the demographic profile of patients admitted with  
     diagnosis of CVT at Government Rajaji hospital during the   
     period from January 2007 to March 2009
2.  To study the clinical presentation of CVT among puerperal 
     CVT, non puerperal female patients with CVT and male patients 
     with CVT
3.  To investigate this patient groups with CT/ MRI & MRV and 
    evaluate the radiological findings & compare among the three       
    groups
4.  To assess the etiology, risk factors associated with CVT among 
     puerperal CVT, non puerperal female patients with CVT and 
    male patients with CVT
5.  To assess the short term outcome among the three groups
                        MATERIALS AND METHODS 
               
The  study  design  was  prospective  one  involving  patients  admitted  in 
Medicine, Obstetrics and Gynaecology, Neuromedicine and all other wards with 
cerebral venous sinus thrombosis  
Patients admitted and diagnosed as having cerebral venous sinus thrombosis 
based on CT/ MRI & MRV were included study group.
Methodology
1.   Symptoms were  recorded in  a  predesigned proforma one allotted for  each 
patient.
2.  Place of delivery and mode of delivery natural or LSCS were recorded. 
3.    Detailed history about risk factors for CVT enquired.
4. Detailed  general  examination  and  neurological  examination  about  the 
presence of papilledema,  focal  deficits  done and documented & compared 
among three groups.
5.   CT / MRI & MRV findings and etiology for the cause of CVT done and 
entered in the proforma. 
6.   Short term outcome analyzed and compared among three groups. 
RESULTS
Table -1   
Age & Sex distribution
Age group (in 
years)
Puerperal CVT 
No  = 44
Non puerperal 
female CVT 
No = 16
Male CVT 
No = 15
10 – 20 4 (9.1%) 3 (18.75%) 2 (20%)
20 – 30 38 (86.36%) 3(18.75%) 5(33.33%)
30 – 40 2 (4.54%) 7 (43.75%) 4(26.66%)
40 – 50 1 (6.25%) 1 (6.66%)
50 – 60 2(12.5%) 2(13.33%)
> 60 yrs - -
Diagram showing the percentage of Puerperal, Non puerperal 
& Male CVT
Puerperal - 44 (59%)
Non puerperal females  - 16 (21%)
Male - 15 (20%)
Table – 2
DIAGRAM SHOWING PERCENTAGE OF PUERPERAL / NON 
PUERPERAL FEMALE / MALE CVT
59%
21%
20%
Puerperal Non puerperal Female Male
Symptoms of cerebral venous thrombosis
No. Symptom
Puerperal 
CVT
No  = 44
Non 
puerperal 
female CVT
No = 16
Male CVT
No = 15
1. Headache 41 (93.18%) 14 (87.5%) 15 (100%)
2. Vomiting 31 (70.45%) 6 (39.5%) 6 (90%)
3. Seizures – Total 29 (65.90%) 6 (39.5%) 7 (46.66%)
    Focal 4 (9.09%) 1 (6.25%)
    Focal – GTCS 2 (4.5%) 2 (12.5%) 1 (6.66%)
    GTCS 19 (43.18%) 3(18.95%) 5 (33.33%)
    EPC 3(6.81%) - -
Status epilepticus - - 1 (6.66%)
4. Altered sensorium 3(6.81%) 3(18.75%) 2(13.33%)
5. Focal  neurological 
symptoms
29 (65.90%) 3(18.75%) 1 (6.66%)
   Right hemiplegia 13(29.59%) 2 (12.5%) -
   Left hemiplegia 13(29.59%) 1 (6.25%) 1(6.66)%
   Monoplegia 1 (2.27%)
   Aphasia 2(4.54%) 1(6.25%) -
Hemianopia 1 (2.29%) - -
6 Fever 3 (6.80%) 1 (6.25%) 1(6.66%)
7. Diplopia - - 1 (6.66%)
Table – 3
Internal between Delivery – Onset of symptoms of 
puerperal CVT
Post partum day Total = 44   No (%)
<   7 days 8 (18.18%)
7 – 9 days 9 (20.97%)
10 – 14 days 22 (50%)
15 – 21 days 5 (11.36%)
>  21 days -
Table – 4
Signs in patients with cerebral venous thrombosis
No. Signs T=44
Puerperal 
CVT
T=16
Non 
puerperal
T=15
Male CVT
1. Altered sensorium 3 (6.81%) 3(18.75%) 2(13.33%)
2. Stupor / Coma - 1 (6.25%) -
3. Ophthalmoplegia 1(2.27%) 1(6.25%) 1(6.66%)
4. Papilledema 31(70.45%) 12(75%) 12(80.1%)
5. Proptosis / chemosis 1 (2.29%) 1(6.25%) -
6. Aphasia 2(4.54%) 1 (6.25%) -
7. Focal neurological 
deficits
29 
(65.90%)
3 (18.75%) 1 (6.66%)
8. Meningeal signs 2 (4.54%) - 1 (6.66%)
Table – 5
Presentation of Cerebral venous thrombosis
Duration Puerperal CVT
No = 44
Non puerperal 
Female
No = 16           
Male CVT
No = 15
Acute < 48 hrs 7(15.9%) 2(12.5%) 1(6.66%)
Sub acute
((48hrs – 30 days)
37(84.09%) 12(75%) 9(60%)
Chronic - > 30 days - 2(12.5%) 5(33.33%)
Diagram – 2 Association between papilledema and CVT
Puerperal CVT                     -   31(70.45%)
Non puerperal female CVT     -   12(75%)
Male CVT                     -   12(80%)
Table – 6
Investigational profile in patients with CVT
S.No.
Parameter
Puerperal 
CVT
No = 44
NP female
No = 16
Male
No = 15
1. Hb
Hb      <  5 gm
           5 - 8 gm
           >  8 gm
-
32(72.72%)
12(27.27%)
-
2(12.5%)
14(87.5%)
-
1(6.66%)
14(93.33)
2. Positive ANA 
& dsDNA
2(4.54%) 2(12.5%) -
3 Positive APLA - 2(12.5%) -
ASSOCIATION BETWEEN PAPILLEDEMA AND CVT
56%
22%
22%
Puerperal Non puerperal Female Male
4. Low serum 
homocysteine
- - 4(26.6%)
5. Abnormal 
coagulation factors 
(proteins C, S,AT III)
NA 3(18.75%) 4(26.6%)
Table – 7
Table showing CT signs in patients CVT
Parameter
Puerperal 
CVT
T = 44
Non 
puerperal 
CVT
T = 16
Male CVT
     T=15
Direct Signs 16(36.36%) 11(68.75%) 7(46.66%)
     Empty delta 5(11.36%) 6(37.5%) 2(13.33%)
     Dense triangle 10(22.72%) 5(31.25%) 5(33.33%)
     Cord sign 1(2.27%) - -
Indirect signs 28(63.63%) 5(31.25%) 9(60.00%)
    Hemorrhagic infarct 24(54.54%) 4(25%) 8(53.33%)
    Non hemorrhagic   
         infarcts
4(9.09%) - -
    Both - 1(6.25%) -
Tentorial / falx 
enhancement
5(11.36%) 2(12.5%) 4(26.66%)
Gyral enhancement - - -
Squashing of ventricles 8(18.18%) 2(12.5%) 4(26.66%)
SAH 1(2.27%) - -
Midline shift 3(6.80%) - -
Normal CT 7(15.90%) 3(18.75%) 2(13.33%)
Thalamic hypodensity - 1 (6.25%) 1 (6.25%)
Table – 8
Table showing sinus involved by  MRV (more than one sinus involved in 
single patient)
Sinus Involved
Puerperal CVT
No = 44
Non puerperal 
female CVT
No = 16
Male CVT
No  = 15
SSS 40 (90.9%)   13 (81.25%) 11 (73.33%)
LS 33 (75.06%) 14 (87.5%) 9 (60.0%)
SS 6 (13.63%) 2 (12.5%) 1 (6.66%)
Jugular vein 1 (2.27%) - -
Deep veins 1 (2.27%) 1 (6.25%)
Cavernous 
sinus
1 (2.27%) 1 (6.25%) -
Anastamotic 
veins
2 (4.53%) - 4 (26.66%)
Table - 9
MRI signs in CVT
Sign
Puerperal CVT 
group No = 44
Non puerperal 
female CVT 
group No = 16
Male CVT group
No = 15
Hemorrhagic 
infarction
     Frontal
     Parietal
     Temporal
     Occipital
     Thalamic
32 (72.72)
12 (27.27)
16 (34.09%)
4 (9.09%)
1 (2.27%)
1 (2.27%)
5 (31.25%)
1 (6.25%)
4 (25%)
-
-
1 (6.25%)
8 (53.33%)
2 (13.33%)
3 (20%)
4 (26.66%)
-
-
Non hemorrhagic 
infarction
    Frontal
    Parietal
    Temporal
    Occipital
    Thalamic
6 (13.63%)
4 (9.09%)
2 (4.54%)
-
-
-
1 (6.25%)
1 (6.25%)
-
-
-
-
1 (6.66%)
1 (6.66%)
-
-
-
-
Both - 1 (6.25%) -
More than one 
location 
(Hemorrhagic   
    infarction)
2 (4.54%) - 1 (6.66%)
Table – 10
Etiological profile in patients with CVT
S.No. Etiology Puerperal 
CVT
Non puerperal 
Female CVT
Male CVT
1. Post partum related 44 NA NA
2. Nephrotic syndrome - - 1(6.6%)
3. Post chicken pox - - 1(6.6%)
4. OCP use - 2(12.5%) -
5. CSOM - - 1(6.6%)
6. Cancer - 1(6.25%) 1(6.6%)
7. Head injury - 1(6.25%) -
8. Connective tissue 
related
1(2.27)% 4(25%) -
9. Inherited  coagulation 
disorders
NA 3(18.75%) 4(26.6%)
Table - 11
Outcome of CVT
Group Puerperal CVT Non puerperal 
Female CVT
Male CVT
Good Recovery 37 (84.09%) 14 (87.15%) 15 (100%)
Residual 
Neurological 
Deficit
6 (13.6%) 2 (12.5%) -
Death 1 (1.33%) - -
DISCUSSION
Government  Rajaji  Hospital,  Madurai  is  the  only  tertiary  referral  care 
hospital  located  in  Madurai  district.   Various  cases  have  been  referred  from 
Government sector hospitals like PHCs,  Taluk hospitals,  District  head quarters 
hospitals, ESI hospital and many private hospital of not only from Madurai but 
also from near by districts.
             The inpatients census crosses one lakh admissions per year from all 
departments.
Our prospective study of CVT patients from January 2007 to March 2009 
included 75 patients. It constituted 0.59% admissions in one year (2007).
DEMOGRAPHY  (Table -1)
Of the total CVT cases males constituted 20% of the cases, and remaining 
were females. This female preponderance 4:1 was largely due to high number of 
postpartum or other obstetric cause related CVT patients (80% of total). This data 
was consistent with previous Indian studies viz. Bansal et al17 (1980), Srinivasan et 
al12  (1983), Nagaraja et al2 (1989). High proportion of postpartum CVT was also 
observed  by  Cantu  et  al7 (1996)  from Mexico.  They  recorded  67  out  of  113 
consecutive patients of CVT temporarily related to postpartum period (60.1%). 
This  high  proportion  of  CVT  cases  not  replicated  in  some  other  studies  viz. 
Deschiens et al53 (1996) and Daif et al28 (1995). The possible explanation may be 
that the etiological factors as well as clinical profile of CVT is different in India 
and other developing countries where still a large number of post partum CVT are 
seen compared to west.  Age of occurrence of CVT varied from 10 years to 60 
years  and more  than  (61.3%) (as  per  table  No.1)   fell  in  the  3rd decade.  Ten 
patients are from second decade (13.33%). The mean age of all patients was 26.64 
years  (range 15-60 years)  similar  to earlier  studies from India (Nagaraja  et  al2 
(1989). However it was significantly lower in puerperal CVT group i.e. (22.79) 
compared to male patients with CVT and female patients of non puerperal CVT 
where it was (31.53) and (32.62) respectively. Similar observation was made by 
Cantu et al from Mexico in his series where average age of obstetric case related 
CVT was significantly lower (twenty versus thirty six years). Majority of the post 
partum CVT in this study (fifty percent) presented ten to fourteen days consistent 
with other studies (Srinivasan et al12 1983, Nagaraja et al2 1987).  
MODE OF PRESENTATION (Table-5)
            Among the puerperal CVT, onset was acute (less than two days) in 15.9%. 
Cantu et al observed that evolution of symptoms was significantly more rapid in 
puerperal than non puerperal group of patients this in contrast to this study only 
15.9% presented acutely.  More common was the sub acute (84.09%) presentation 
in our study. Among non puerperal CVT, sub acute presentation predominated the 
clinical feature (75%) of total cases. Among the male CVT presentation was sub 
acute (60%) and chronic (33.33%) cases.  (Table no 5)
MAJOR CLASSES OF CVT (Diagram No.1)
Of the total CVT in our study,  puerperal CVT constituted 58.66%, female 
non puerperal CVT constituted 21.33% and males 20% which is comparable to 
ISCVT study ( Jose M Ferro et al51 2003) in which males constituted 25.5% and 
females ( puerperal & non puerperal ) accounted for 74.5 % .   
CLINICAL PROFILE (Table-2&4)
Head ache is the major complaint in all classes of CVT which constituted 
93.18%, 87.5%, 100% of cases in puerperal CVT, non puerperal CVT and male 
CVT respectively. This in contrast to the various Indian series where the patients 
presenting with headache was less  (48% in Bansal  et  al  study17 1980,  24% in 
Srinivasan  et  al12 study  1983,  70.8%  in  Nagaraja  et  al  21989).    Among  the 
puerperal CVT group focal deficits, seizures predominant the picture (65.9% and 
65.9%).  Among  non  puerperal  CVT,  seizures  (37.5%)  and  altered  sensorium 
(18.75%)  predominate  the  clinical  feature.  Among  male  CVT patients,  GTCS 
alone  (33.33%)  dominated  the  clinical  picture  and  focal  neurological  deficits 
occured only in 6.66%. This is in comparison with various Indian studies 17,2,12 of 
CVT. Seizures occurred in 65.90 % of puerperal CVT as compared to 37.5% of 
patients in non puerperal group and 46.66 % patients in male CVT group. Aphasia 
was present in 2 patients (4.54%) in puerperal group and one patient (6.25%) in 
non puerperal group. This in contrast to the study by Cantu et al (1993) 25.3% of 
patients in puerperal and 21.7 % patients in non puerperal group had aphasia. 
Of the puerperal CVT mean day of occurrence of CVT was 12  + 2 days 
which in comparison with Indian studies (Srinivasan et al12  1983, Nagaraja et al2 
1987).  
Examination findings revealed papilledema in 70.45% of puerperal  CVT, 
75% of non puerperal CVT, 80% male CVT which in contrast to study by Bansal 
et al 17 and Nagaraja et al in which papilledema was present only in 35% and 58% 
respectively. High incidence of papilledema in this study possibly due to the more 
sub acute presentation of our patients compared to the above mentioned studies.
Focal neurological deficits like hemiplegia, monoplegia occurred in 61.45 % 
patients with puerperal CVT, 18.75 % patients with non puerperal female group 
and 6.66% patients with male CVT. This is in contrast to the study by Cantu et al 
(1993) who compared the neurological findings in puerperal and non puerperal 
group. In his study focal motor signs were present in 77.6% in puerperal group and 
76% patients in non puerperal group. 
Altered sensorium occurred in 18.75% of non puerperal CVT and 6.81% of 
puerperal CVT and 13.33% of patients with male CVT. Meningeal signs present in 
4.5% of puerperal CVT, 6.66% of patients with male CVT which in contrast to 
various  Indian  series  where  the  percentage  of  patients  presenting  with  altered 
sensorium and meningeal signs are around forty to fifty eight percent.  
Neurological findings in Puerperal and non puerperal CVT compared with 
Cantu et al study
                            
OUR STUDY Study by  Cantu et al 1993
No. Findings Puerperal Non puerperal Puerperal Non puerperal
N % N % N % N %
Headache 41 93.18 14 87.5 59 88 32 69.5
Focal signs
   Motor
   Sensory
29 65.9 3 18.75
53
52
25
79.1
77.6
37.3
35
33
13
76
71.7
28.2
Aphasia 2 4.54 1 6.25 17 25.3 10 21.7
Disorder  of 
consciousness
3 6.81 3 18.75 42 62.6 27 58.6
Somnolence - - - - 24 35.8 9 19.5
Stupor/coma - - 1 6.25 16 23.9 15 32.6
Confusion - - - - 2 2.9 3 6.5
Seizures 29 65.90 6 37.5 40 59.7 29 68.0
Generalized 19 43.18 3 18.75 18 26.9 16 34.8
Focal 4 9.09 1 6.25 22 32.8 13 28.2
Bilateral 
pyramidal signs 
- - - - 28 41.7 18 19.1
10. Papilledema 31 70.45 12 75 27 40.2 24 52.1
11. Nuchal rigidity 2 4.54 - - 22 32.8 12 26.0
12. Isolated 
intracranial 
hypertension
- - - - 5 7.4 8 17.3
BLOOD INVESTIGATIONS (Table -6)
Anemia of moderate degree (5 to 8 gm) was present in 72.72% of puerperal 
CVT but only in 12.5% and 6.6% of non puerperal  and male CVT. This high 
percentage of anemia has been reported from various Indian studies2, 17, 12.  Whether 
this reflects the anemia in the general population reflecting more severely in the 
puerperal  group  is  not  known.  Investigations  like  ANA,  dsDNA,  APLA  and 
coagulation profile were done only in limited number of patients which may be 
related to cost and availability factors.  Of the patients subjected for ANA, dsDNA 
only 4.54% & 12.5 % of puerperal,  non puerperal CVT patients were positive. 
Antiphospholipid antibodies were positive in only two patients with non puerperal 
CVT. None in the male CVT group was positive.  High serum homocysteine   was 
present in 26.66 % male patients with CVT. Evaluation for abnormal coagulation 
factors  like  Protein  C,  Protein  S  and  AT  III  deficiency  done  and  positive  in 
18.75% and          26.66 % of patients in non puerperal and male CVT group.   
NEURO IMAGING – CT Scan (Table-7)
Of the total  CVT patients  98.66 % of  patients  underwent  CT, 100 % of 
patients underwent MRI.  Of all patients subjected to CT direct signs of present in 
45.33 % of patients.  This in contrast to the study Cantu et al (1993) in which 
direct signs of CVT present only in 32.68%.   Indirect signs present in 56% of 
patients with CVT in our study. This in contrast to study by Cantu 72.7% had 
indirect signs of CVT like hemorrhagic infarction, non hemorrhagic infarction and 
hematoma. In a study of 68 patients by Nagaraja et al (1989) 22 had direct signs of 
CVT and 59 had evidence of infarction. Normal CT scans in 16 % of total patients 
in our study group.  This in contrast with Cantu et al (1993) study in which normal 
CT scan was present only in 9.47%. Among direct signs empty delta signs present 
in 17.33% of  patients,  dense triangle sign in 26.66% patients  & cord signs in 
1.33% of patients. Dense triangle sign in puerperal group (22.72%), empty delta 
sign in non puerperal group (37.5%) and male CVT (33.33%) were the commonest 
findings. This in contrast to a study by Cantu et al (1993) cord sign and empty 
delta signs were present in 32 out of 95 patients (33.68%). In a study of 65 patients 
with CVT by Nagaraja et al (1989) cord sign was present in 14 out of 65 patients 
(21.53%) but in our study it was present only in 1.33% of patients. Among indirect 
signs hemorrhagic infarct and non hemorrhagic infarct was present in 48% and 
6.66% of patients. Hemorrhagic infarct present in parietal region in 37%, frontal 
region  25.3%,  temporal  region  8  %  and  occipital  region  1.33%,  of  patients. 
Bilateral  thalamic hypo density  was present  in 2.66% patients suggesting deep 
veins  involvement.    Squashing  of  ventricles  seen  in  18.66%  of  patients. 
Subarachnoid hemorrhage occurred in only in one patient.    
                Comparison of CT findings in various studies 
CT finding Present study
No = 75
Nagaraja et al 
1989.  n = 65
Cantu et al 1996. 
n = 95
Infarction 42 59 67
Cord sign 1 14 32 ( cord + 
empty delta sign)
Empty delta 13 8 See above
Normal 12 1 9
MRI & MRV (Table – 8 & 9)
Venous sinus involved in our study compared with others studies as 
follows. 
Sinus 
Involved
Present study 
No = 75(%) 
ISCVT study, Jose M Ferro et al 
2003.          No = 624(%)
SSS 64(85.33%) 313(62%)
LS 56(74.66%) 536(85.9%)
SS 9(12%) -
JUGULAR 
VEIN
1(1.33%) 74(11.9%)
Cavernous 
sinus 
2(2.66%) 74(11.9%)
Deep veins 2(2.66) 68(10.9%)
Anastamotic 
veins 
6(8%) -
In  our  study  as  compared  with  ISCVT  study  had  high  percentage  of 
involvement  of  SSS  and  lower  incidence  of  LS,  jugular  vein,  deep  vein 
thrombosis. In our study the SSS thrombosis was 90.90% in puerperal group as 
compared with 81.25%, 73.32% of  patients  in  non puerperal  female  and male 
CVT. LS is involved only in 60 % of male patients with CVT.  Vein of Labbe 
thrombosis with hemorrhage in the temporoparietal region in six of study patients 
(2 in puerperal, 4 in male). One of our young patients had evidence of cerebellar 
tuberculoma in association with CVT. 
Among  the  parenchymal  lesions  in  MRI,  hemorrhagic  infarction 
predominated in all three groups. 72.72% of puerperal CVT group, 31.25% in non 
puerperal group and 53.53 % in male CVT group had hemorrhagic infarction. In 
our study 44% of patients had hemorrhagic infarction in parietal region and 20% 
in  frontal  region.  Non  hemorrhagic  infarction  was  present  only  in  10.66% of 
patients of total CVT in our study. This in contrast to a study by Cantu et al (1993) 
in which hemorrhagic infarction accounted for 52.6% in puerperal CVT group and 
55% in non puerperal CVT group. 
ETIOLOGY (Table – 10)
Out of total 75 patients of CVT, venous thrombosis related to pregnancy was 
in 58.66%. In non puerperal female CVT group, CVT was related to intake of 
OCP in 12.5%.  one  (2.27%) patient &  three (18.75) patients in nonpuerperal 
female group had cancer and connected tissue disorder respectively as a risk factor 
for CVT.  In male patients, CVT was related to nephrotic syndrome in one patient 
(6.66%), exanthematous fever (chicken pox) in one patient (6.66%), CSOM in one 
patient (6.66%), and cancer in one patient (6.66%).  Head injury as risk factors of 
CVT in only one patient in non puerperal group.  Inherited coagulation disorders 
were the risk factors of CVT in 9.33% of patient with total CVT. This very low 
percentage was related to less number of patients underwent these investigation 
because of cost factors. Alcoholism was a major risk factor for male patients with 
CVT in our study (53.33%)  
OUTCOME  (Table – 11)
13.63% patients  in  puerperal  group and 12.5% patients  in  non puerperal 
group had residual neurological deficit & none in male CVT group.   One patient 
(2.27%) died in puerperal CVT group. No death occurred in non puerperal CVT 
and male CVT group. 
        SUMMARY & CONCLUSION
1. Over a period of 27 months, 75 patients of cerebral venous thrombosis 
were studied.  Almost more than one half (58.66%) of patients were post 
partum CVT, data consistent with most Indian studies.
2. CVT still remains a disease of young adults.  In this study, 61.33% of 
patients were below 30 years of age.  
3. Mean age was significantly lower in puerperal group compared to non 
puerperal group.
4. Majority of post partum CVT patients presented with in 10-14 days after 
delivery.
5. Majority in our study presented subacutly (48 hrs – 30 days). There was 
no significant difference between puerperal and nonpuerperal group (non 
puerperal female and male CVT).
6. Headache  (70/75),  Seizures  (42/75),  and  focal  neurological  deficits 
(33/75) were the major clinical features noted.  There was no difference 
between  puerperal,  non  puerperal  female  and  male  CVT  in  terms  of 
frequency of these symptoms.
7. Haemoglobin  value  of  less  than  8  gm  in  46.66%  of  total  CVT.  In 
puerperal  group,  this  number  was  high  (72.72%)  compared  to  non 
puerperal female CVT and male CVT.
8. Cerebral infarction was the most common abnormality noted on the CT 
scan (56%) which was haemorrhagic in most of the cases.  Deep seated 
venous thrombosis noted only in 2.66% (2/75) of patients.  1 in puerperal 
group and 1 in non puerperal female CVT group.
9. On MRI most common sinus involved in all the three groups was SSS 
(67/75)  89.33%.  The  next  common sinus  involved  was  LS (74.66%). 
There was no significant difference in puerperal, non puerperal and male 
CVT group in the frequency of SSS and LS involvement.
10. In MRI haemorrhagic infarction was present in 72.72%, 31.25%, 53.33% 
of  patients  in  puerperal,  non  puerperal  female  and  male  CVT  group 
respectively. Haemorrhagic infarction is most commonly present in the 
parietal region in 23/75 patients. Frontal haemorrhagic region was present 
less commonly (15/75 patients). One  patient had occipital haemorrhagic 
infarct  in puerperal  group.  Haemorrhagic infarction in more than one 
location was present in 4% (3/75) total patients with CVT.
11. 44 out of 75 patients the venous thrombosis was related to puerperium. 
Evaluating  the  risk  factors  for  CVT  in  non  puerperal  group  showed 
association with OCP intake in 2 patients, Related to cancer CVT in one, 
related to SLE in three (18.75%).  Head injury was the risk factor for 
CVT in one non puerperal CVT patient.  Among male patients with CVT 
nephritic  syndrome,  chicken  pox,  CSOM,  Cancer  each  one  was 
associated in CVT in single patient.  Among male CVT group alcoholism 
was the major risk factor (53.33%).
12. Out come was better in male patients with CVT since no death or residual 
neurological deficit was reported. 2 out of 16 patients in nonpuerperal 
group had residual neurological deficit.  In puerperal group, 1 patient died 
and 6 had residual neurological deficit.
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ABBREVIATIONS
CVT Cerebral Venous Thrombosis
SSS Superior Sagittal Sinus
LS Lateral Sinus
SS Sagittal Sinus
GTCS Generalised Tonic clonic Seizures
EPC Epilepsia Partialis Continua
CT Computed Tomography
MRI Magnetic Resonance Imaging
MRV Magnetic Resonance venography
SAH Subarachnoid haemorrhage
ICH Intra Cerebral Haemorrhage
LMWH Low molecular weight heparin
ANA Anti Nuclear Anti body
dsDNA Double standard Deoxy ribo Nucleic Acid
APLA Anti Phospholipid Antibody
CSOM Chronic Suppurative Otitis Media
NA Not Applicable
PROFORMA
S.No:                                                            D.O.A:                         D. of Delivery: 
Name                                Age/ Sex             D.O.D:  
Para:             Gravida:                                  Interval between delivery & first symptom:
SYMPTOMS:                                             Interval between first symptom & admission:
Headache:                                 Duration:                            Site:   
                                                   Type:         
Vomiting   :  
Seizures:               Focal:             Generalized:            Focal – generalized:                 EPC:
                              Status epilepticus: 
Consciousness:     Normal / Altered: (Duration):                                      
Focal deficits:       Motor: Hemiparesis / monoparesis / paraparesis / tetraplegia
                              Sensory:                                                 Visual:     
Mental symptoms:      Normal / confused / apathetic / others 
Fever: 
Course since the onset of symptoms:       static / improving / progressing     
Delivery:   Home/ PHC/ Nursing home/ GRH                      Normal / LSCS       
PAST HISTORY :
CVT:                DM:               HT:                  Seizures:                       Hematological disorder: 
Ear discharge:                       OCP:               Renal disease:                 Alcohol intake: 
Exanthematous fever:                       Cancer:                                      Recent surgery: 
Bloody diarrhea:                               Vasculitis (rash, arthritis):                    
EXAMINATION:
Pulse:            BP:                    Temp:                                       
Dehydration:                          Thrombophelibitis:                            DVT:                            
Consciousness:                       Orientation:                                       Behaviour:  
Language:                                        
Meningeal signs:                   Visual acuity:                         Eye movements: 
Pupils:                                    Fundus:                                   
Facial weakness                    Deafness                               Dysphagia
Motor system                        Weakness                              Power                             Tone
Reflexes     
Sensory system                      
Bladder involvement
Cerebellar signs 
CVS                                    RS                                           ABDOMEN 
INVESTIGATONS: 
Hb                               ESR:                    TC:                                  Urine:  
BT                               CT                     ANA:                               S. Homocysteine    
PS                                                          APLA:                           
Blood sugar                              Urea                            S.Creatinine:                       LFT      
Electrolytes                              CXR                            S.Fibrinogen 
ECG                                               Others – (Protein C & S, AT III)                                                  
CT scan:        plain / contrast                  Normal / Abnormal                     
 Direct signs – empty delta sign / dense triangle sign / cord sign (SSS / LS /Medullary) 
 Indirect signs – hemorrhagic infarct / non hemorrhagic infarct / both  
                                   Location - frontal / parietal / temporal / occipital / thalamic   
 Tentorial / falx enhancement    
 Gyral enhancement                                            SAH 
 Mass effect - squashing of ventricles / midline shift / obliteration of basal cisterns 
MRI & MRV: 
             Hemorrhagic infarct / non hemorrhagic infarct / both  
             Location - frontal / parietal / temporal / occipital / thalamic   
             Stage of sinus thrombosis
             Sinus involved – SSS / LS / SS / Cavernous sinus / Deep veins / combinations                        
                                         Anastamotic veins 
OUTCOME:
      PRESENTATION  :    acute / subacute / chronic                         Septic / Aseptic 
SINUS INVOLVED:   SSS / LS/ TS/ SS / Cortical vein / Deep venous system  
DIAGNOSIS:  Puerperal CVT / Non Peurperal CVT in Females / Male CVT 
KEY TO MASTER CHART
Puerperal state                        
1. Puerperal      2. Non puerperal      3.  Not applicable 
Headache
0 – absent 1- present
Vomiting       
      0 – absent 1- present
Seizures           
0 – absent  1- focal  2- focal – generalized  
3- GTCS  4-   EPC 5- Status epilepticus
Altered sensorium     
0 – absent 1- drowsy  2- stupor / coma 
Fever    
0 – absent, 1- present
Focal neurological deficit   
0 –absent 1- Rt hemiplegia 2-Lt hemiplegia    
3- Monoplegia Rt  4- monoplegia Lt   5- Homonymous hemianopia 
Aphasia     
0 – absent 1- present
Diplopia     
0 – absent 1- present
Opthalmoplegia   
 0 – absent, 1- present
Papilledema   0 – absent, 1- blurring of nasal margins, 
  2 - established Papilledema, 
  3 - papilledema + fundal hemorrhages 
Inteval between delivery & onset of symptoms of CVT 
      0  - not applicable ,  1-  ≤ 7 days , 2-    7-9 days,
 3 -   10-14 days, 4-  15-21 days, 5- > 21 days.  
Hb(gms)   
    1-  ≤ 5 gms  2- 5-8 gms   3- > 8 gms
 Vasculitic profile 
   0- negative    1- positive ANA      2-  positive ANA & ds DNA
 3- positive  APLA           4-  not done 
Coagulation factors   
0- normal  1- low protein C      2- low protein S 
3- low AT III       4- not done 
CT scan findings  
 0- normal 1-Empty delta sign        2- dense triangle sign  
 3- cord sign           4-hemorrhagic infarct 
 5- both hemorrhagic infarct& non hemorrhagic infarct 
 6-tentorial / falx enhancement                 7- gyral enhancement
 8-squashing of ventricles     9- SAH
 10- mid line shift  11- non hemorrhagic infarct      12- not done 
MRI sinus involved
1- SSS  2- LS 3- SS 4- SSS+LS 
5- SSS+LS+SS  6- LS+SS 7-SSS+LS+SS+Jugular vein
8- cavernous sinus   9- deep venous system 
Out come 
1- Good recovery 
2- residual neurological deficit
3- death 
MRI  BRAIN  T2WI  SHOWING 
BILATERAL PARIETAL HAEMORRHAGIC INFARCTION
MRI BRAIN SHOWING HAEMORRAGE IN TEMPORAL REGION IN A 
PATIENT WITH LATERAL SINUS THROMBOSIS
MRI MID SAGITTAL SECTION SHOWING EVIDENCE OF SUPERIOR 
SAGITTAL SINUS THROMBOSIS
MRV SHOWING LATERAL SINUS THROMBOSIS
